Latest Asx News

AVITA Medical has lodged a new $200 million shelf registration with the SEC, renewing its capacity to issue various securities in the US market. While no immediate capital raising is planned, this move preserves the company’s financial agility for future growth opportunities.

OzAurum Resources reports exceptional heap leach test results at Mulgabbie North, confirming rapid gold recovery and advancing a low-capex development strategy with near-complete plant refurbishment.

Lachlan Star Limited has raised $7.47 million through a share placement to accelerate exploration at its New Waverley Gold Project in Western Australia’s Norseman region. The capital injection positions the company to rapidly test high-potential gold targets and expand its drilling program.

Since its October 2025 ASX IPO, Temas Resources has made significant strides in commercialising its proprietary metallurgical technology and advancing its Québec mineral projects, supported by solid financial reserves.

The Australian Treasurer has issued interim directions preventing Hong Kong Ying Tak Limited from transferring or voting over 361 million shares in Northern Minerals, amid suspected breaches of foreign investment disposal orders. Northern Minerals is cooperating with regulators while focusing on its rare earths project.

Globe Metals & Mining’s 2026 Bankable Feasibility Study for the Kanyika Niobium Project in Malawi confirms robust economics, a 24-year mine life, and a strategic phased development approach.

St George Mining has partnered with Boston Metal to trial a cutting-edge molten oxide electrolysis technology at its Araxá Project, aiming to revolutionise niobium production with lower costs and emissions.

POSCO Holdings has postponed its investment decision on Anson Resources’ Green River lithium demonstration plant due to global uncertainties, yet maintains strong collaboration and strategic commitment.

Prospect Resources has confirmed a continuous near-surface copper sulphide system over more than 1km at its West Mwombezhi prospect in Zambia, with a maiden resource estimate due in Q2 2026.

Count Limited has successfully raised $35.9 million through an institutional placement to partially fund its acquisition of Oracle Group Ltd, while also launching a $5 million Share Purchase Plan for existing shareholders.

Actinogen Medical has initiated the open-label extension of its XanaMIA Alzheimer’s trial, offering all participants active Xanamem treatment for up to 25 months to gather long-term safety and efficacy data ahead of final trial results.

OMG Group has inked a collaboration with Sydney’s The Little Marionette to supply premium Japanese matcha, reinforcing its vertically integrated matcha strategy and expanding its reach into premium hospitality and retail sectors.